Sonova AG
Stäfa, Canton of Zurich, 8712, Switzerland
NCT Number: NCT03780374
A methodical evaluation of novel sound changing principles in CE-labelled Sonova brand hearing instruments (e.g. Phonak hearing instruments) is intended to be conducted on hearing impaired. These sound changing principles are enabled by respective hearing instrument algorithms. The aim of the study is to investigate and asses strength and weaknesses of these novel sound changing principles in terms of hearing performance to determine their application in hearing instruments (Phase of development). Both, objective laboratory measurements as well as subjective evaluations in real life environment will be carried out. This will be a controlled, single blinded and randomized active comparator clinical evaluation which will be conducted mono-centric at Sonova AG Headquarter based in Staefa.
Looking for future studies?
Notify Me18 year–99 year
All sexes
Interventional
Not applicable
Stäfa, Canton of Zurich, 8712, Switzerland
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Compensation of a hearing loss with Sound Processing Principle 1.
Compensation of a hearing loss with Sound Processing Principle 2.
Compensation of a hearing loss with Sound Processing Principle 3.
Time frame: 4 weeks
The speech intelligibility in noise with the three different sound processing principles will be assessed with the aid of the Oldenburg Sentence Test. The result will be shown in dB (decibel) SRT (Speech Reception Threshold).
Time frame: 16 weeks
The overall sound quality of sounds with the three different sound processing principles will be assessed with the aid of a questionnaire.
The results are ratings on a numeric scale, ranging from 0 (bad) to 10 (excellent).
Time frame: 8 weeks
The loudness of sounds with the three different sound processing principles will be assessed in laboratory with the aid of a MUSHRA (Multi-Stimulus Test with Hidden Reference and Anchor) test.
The results are ratings on a numeric scale, ranging from 0 (very soft), 50 (just right) to 100 (very loud).
Time frame: 16 weeks
The loudness of sounds with the three different sound processing principles will be assessed in daily life with the aid of a questionnaire.
The results are ratings on a numeric scale, ranging from 0 (very soft) to 10 (very loud).
Time frame: 16 weeks
The clarity of sounds with the three sound processing principles will be assessed with the aid of a questionnaire.
The results are ratings on a numeric scale, ranging from 0 (very unclear) to 10 (very clear).
Time frame: 16 weeks
The preferred sound processing principle will be assessed with the aid of a questionnaire.
The results will be a ranking, ranging from 1 (most preferred) to 3 (least preferred).
Time frame: 16 weeks
The sound quality with the three different sound processing principles will be assessed with the aid of a questionnaire.
The results are ratings on a numeric scale, ranging from 0 (unnatural) to 10 (natural).
Time frame: 16 weeks
The ability to localize sounds with the three different sound processing principles will be assessed with the aid of a questionnaire.
The results are ratings on a numeric scale, ranging from 0 (not at all locatable) to 10 (very well locatable).
Time frame: 16 weeks
The reverberation of sounds with the three different sound processing principles will be assessed with the aid of a questionnaire.
The results are ratings on a numeric scale, ranging from 0 (not at all reverberant) to 10 (very reverberant).
Time frame: 16 weeks
The overall satisfaction in daily life with the three different sound processing principles will be assessed with the aid of a questionnaire.
The results are ratings on a numeric scale, ranging from 0 (very dissatisfied) to 10 (very satisfied).
Sonova AG
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05219474
Ear Diseases, Hearing Disorders
New York, United States
View Trial DetailsNCT01805167
Ear Diseases, Hearing Disorders
Nice, France
View Trial DetailsNCT05070429
Aging, Ear Diseases
Hagerstown, Maryland, United States
View Trial DetailsNCT07501312
Ear Diseases, Hearing Disorders
Aurora, Illinois, United States
View Trial Details